Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

Author： Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.4, 2013-04, pp. : 403-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The safety of novel drugs used to treat irritable bowel syndrome

By Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 625-638

Informa Healthcare

Access to resources Recommend Favorite

The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation

By Rangel Erika B  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1531-1548

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for irritable bowel syndrome

By Shekhar Chander   Whorwell Peter J  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 4, 2009-12 ,pp. : 673-685

Informa Healthcare

Access to resources Recommend Favorite

New Drugs in the Management of the Irritable Bowel Syndrome

By Farthing M.J.G.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 11-21

Adis International

Access to resources Recommend Favorite

The use of psychotropic drugs in irritable bowel syndrome

By Dekel Roy   Drossman Douglas A   Sperber Ami D  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 329-339

Informa Healthcare

Access to resources Recommend Favorite